Skip to main content

Table 3 Results of drug susceptibility testing of 19 Malassezia sp. isolates, as determined by Neo-Sensitabs assay

From: Distribution of Malassezia species on the skin of patients with atopic dermatitis, psoriasis, and healthy volunteers assessed by conventional and molecular identification methods

Malassezia sp. (no.)

Antifungal druga

CPO

FLZ

KTZ

ITZ

ECZ

MNZ

Zone [mm]b

Cat. (no.)c

Zone [mm]

Cat.(no.)

Zone [mm]

Cat. (no.)

Zone [mm]

Cat. (no.)

Zone [mm]

Cat. (no.)

Zone [mm]

Cat. (no.)

M. sympodialis (13)

28

S (13)

43

S (13)

33.9

S (13)

36.5

S (13)

24.5

S (12)

26.5

S (13)

17

I (1)

M. furfur (2)

23

S (2)

36

S (2)

30

S (1)

29

S (2)

15.5

I (2)

20

S (1)

25

I (1)

17

I (1)

M. furfur + M. sympodialis (2)

22.5

S (2)

39

S (2)

25.5

I (2)

28.5

S (2)

14.5

I (2)

20

S (1)

15

I (1)

M. slooffiae (1)

30

S (1)

45

S (1)

35

S (1)

45

S (1)

30

S (1)

20

S (1)

M. slooffiae + M. sympodialis (1)

30

S (1)

40

S (1)

40

S (1)

40

S (1)

30

S (1)

16.5

I (1)

  1. aCPO, ciclopirox; FLZ, fluconazole; KTZ, ketoconazole; ITZ, itraconazole; ECZ, econazole; MNZ, miconazole; number of isolates are given in brackets.
  2. bInhibition zone diameter mean value [mm] (each isolated was tested twice).
  3. cSusceptibility categorization (S, susceptible; I, intermediate; R, resistant) based on the following criteria: CPO, ECZ, MNZ: S, ≥ 20; I, 12–19; R, ≤ 11; FLZ: S, ≥ 22; I, 15–21; R, ≤ 14; ITZ: S, ≥ 16; I, 10–15; R, < 10; KTZ: S, ≥ 30; I, 23–29; R, ≤ 22.